Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Roche Philippines Cuts Tamiflu Price In Fight Against H1N1

This article was originally published in PharmAsia News

Executive Summary

Roche Philippines announced a price cut for its Tamiflu (oseltamivir) flu drug in the Philippines as part of an effort to ensure an adequate supply of the drug worldwide. Other antiviral drugs are expected to be lowered to compete with Roche, which said it was lowering its price to allow the drug to be more affordable for the nation to treat the H1N1 flu virus threat. The drug is not patented in the Philippines, so generics makers are free to market their own versions in the country. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts